|
Bretylium TosylateDrug - Bretylium Tosylate The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Bretylium Tosylate
Strength -
50MG/ML
Applicant -
ASTRAZENECA
New Drug Application (NDA) Number -
071153
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 10, 1987
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Astrazeneca Lp
Bretylium Tosylate
Tracleer 62.5mg Tablet; Oral
Bretylium Tosylate 100mg/ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection Bretylium Tosylate 50mg/ml Injectable; Injection Bleomycin Sulfate Eq 15 Units Base/vial Injectable; Injection Bleomycin Sulfate Eq 30 Units Base/vial Injectable; Injection Velcade 3.5mg/vial Injectable; Intravenous Tracleer 125mg Tablet; Oral NewDrugInformation |